Innovations In Market Access: The Will, But Not The Way?
Innovations In Market Access: The Will, But Not The Way?
$200.00
An informal round table discussion among more than 20 key market access leaders in biopharma convened by the Boston Consulting Group (BCG) yielded some interesting insights into the innovations that are forcing changes to the way the industry runs.
Author: William Looney
Publisher: InVivo
- Description
Get an inside look at how biopharma market access leaders are viewing the current state of affairs in the industry in regards to patients, payers, and regulators with this article from In Vivo. In concert with the Boston Consulting Group (BCG), In Vivo convened a gathering of more than 20 biopharma leaders to discuss where the industry stands today, and how it may be adapting to new innovations in market access in the future. Find out what the leaders had to say in these informative excerpts of their opinions.
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Gene Therapy Investment At All Time High, Commercialization Challenges Note... 
Sign up to the